---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-055468"
form_type: "8-K"
ticker: "SSII"
cik: "0001676163"
company_name: "SS Innovations International, Inc."
filed_at: "2026-05-13T12:30:18+00:00"
generated_at: "2026-05-13T12:35:53.657018+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# SS Innovations Q1 revenue $11.1M (+117% YoY); net loss narrows to $3.6M; installations up 73%

## Summary
- Revenue $11.1M, up 116.8% YoY from $5.1M; gross margin 48.0% vs 21.2% in Q1 2025.
- Net loss $3.6M ($0.02/share) vs $5.7M ($0.03) in Q1 2025; cash $16.0M, no long-term debt.
- SSi Mantra installations 26 (+73% YoY); cumulative installed base 194 across 11 countries; 9,744 cumulative surgeries.
- Regulatory approvals: NMRA (Sri Lanka) and PPB (Kenya); telesurgery approvals in Indonesia and Philippines.
- March 2026 private placement raised ~$18.6M gross; FDA 510(k) review expected in 2026 and CE marking pathway.

## SEC filing metadata
- accession: 0001213900-26-055468
- form_type: 8-K
- ticker: SSII
- cik: 0001676163
- company_name: SS Innovations International, Inc.
- filed_at: 2026-05-13T12:30:18+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676163/000121390026055468/0001213900-26-055468-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676163/000121390026055468/ea0290453-8k_ssinnovations.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-055468
- JSON: https://secwatch.observer/filing/0001213900-26-055468.json
- Plain text: https://secwatch.observer/filing/0001213900-26-055468.txt

## Key facts
- Earnings Releases
  SS Innovations International, Inc. reported the three months ended March 31, 2026 results: revenue $11.1 million, EPS $(0.02) per diluted share.
  - Period: the three months ended March 31, 2026
  - Revenue: $11.1 million
  - EPS: $(0.02) per diluted share
  - Result: reported results
  source text: Report on Form 10-Q for the quarter ended March 31, 2026, with the Securities and Exchange Commission on May 13, 2026. First Quarter 2026 Overview ● Revenue increased 116.8% to $11.1 million from $5.1 million in the first quarter of 2025. ● Gross margin expanded to 48.0% from 21.2% in the first quarter of 2025. ● Gross profit rose 390.0% to $5.3 million from $1.1
  evidence_url: https://www.sec.gov/Archives/edgar/data/1676163/000121390026055468/0001213900-26-055468-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.